Skip to content

Press Releases

Every day, more lives are transformed all over the world – one healthy habit at a time. Read the latest about how Medifast and the OPTAVIA® movement is impacting people’s lives.

Medifast Reports Record First Quarter Revenues

Medifast, Inc. announced today that it expects to report record first quarter revenues for the period ended March 31, 2005. The Company had unaudited revenues of approximately $8.3 million, or a 22% increase versus the period ended March 31, 2004 when the Company had revenues of $6.8 million.

Medifast's growth throughout the first quarter was primarily attributable to its effective advertising campaign, which increased consumer interest in the Medifast brand. "The Company is very excited about its first quarter revenues," said Michael S. McDevitt, Medifast's President. "The Company expects to see continued growth throughout the remainder of the year from increased advertising initiatives, our Take Shape for Life division and Hi-Energy Weight Control clinics."

In March, the Company announced that it had signed a licensing agreement with a regional drug chain. This agreement between Medifast's Hi-Energy Weight Control Centers and Kerr Drug was featured in the April 4, 2005 issue of Drug Topics Magazine. The centers are part of a "store within a store" program under the clinical pharmacy program. Two stores are set to open this month in the Raleigh, NC area and another is scheduled to open next month in Greensboro, NC. This concept has been receiving wide attention in clinical pharmacy circles within the retail industry.

About Medifast: (

Medifast has been helping people lose weight and achieve better health for almost 25 years. Its meal replacement foods have been proven effective at Johns Hopkins University, recommended by over 15,000 physicians and used by more than 1,000,000 customers. Medifast offers its customers world-class customer service, technical and medical support.

This release contains forward-looking statements, which may involve known, and unknown risks, uncertainties and other factors that may cause Medifast's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. Medifast cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectation on this date.

SOURCE: Medifast, Inc.

CONTACT: Jeremy Hunt, Investor Relations Specialist, Medifast, Inc.,